Hippocampus and its involvement in Alzheimer's disease: a review
Hippocampus is the significant component of the limbic lobe, which is further subdivided into
the dentate gyrus and parts of Cornu Ammonis. It is the crucial region for learning and …
the dentate gyrus and parts of Cornu Ammonis. It is the crucial region for learning and …
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
CPC Galts, LEB Bettio, DC Jewett, CC Yang… - Neuroscience & …, 2019 - Elsevier
Major depressive disorder (MDD) is a highly prevalent psychiatric disorder and a major
cause of disability worldwide. This neurological condition is commonly associated with …
cause of disability worldwide. This neurological condition is commonly associated with …
New frontiers in the prevention, diagnosis, and treatment of Alzheimer's disease
L Guzman-Martinez, C Calfío, GA Farias… - Journal of …, 2021 - content.iospress.com
One of the major puzzles in medical research and public health systems worldwide is
Alzheimer's disease (AD), reaching nowadays a prevalence near 50 million people. This is a …
Alzheimer's disease (AD), reaching nowadays a prevalence near 50 million people. This is a …
Optimizing detection of Alzheimer's disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO
Background Disease-modifying drug use necessitates better Alzheimer disease (AD)
detection. Mild cognitive impairment (MCI) leverages cognitive decline to identify the risk …
detection. Mild cognitive impairment (MCI) leverages cognitive decline to identify the risk …
Alzheimer's disease: biomarkers in the genome, blood, and cerebrospinal fluid
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that slowly destroys
memory and thinking skills, resulting in behavioral changes. It is estimated that nearly 36 …
memory and thinking skills, resulting in behavioral changes. It is estimated that nearly 36 …
Biomarkers for Alzheimer's disease
L Guzman-Martinez, RB Maccioni… - Current Alzheimer …, 2019 - ingentaconnect.com
Alzheimer´ s disease (AD) and related forms of dementia are increasingly affecting the aging
population throughout the world, at an alarming rate. The World Alzheimer´ s Report …
population throughout the world, at an alarming rate. The World Alzheimer´ s Report …
The Netrin-1/DCC guidance cue pathway as a molecular target in depression: translational evidence
The Netrin-1/DCC guidance cue pathway plays a critical role in guiding growing axons
toward the prefrontal cortex during adolescence and in the maturational organization and …
toward the prefrontal cortex during adolescence and in the maturational organization and …
Differential and subtype-specific neuroimaging abnormalities in amnestic and nonamnestic mild cognitive impairment: A systematic review and meta-analysis
While mild cognitive impairment (MCI) has been classified into amnestic MCI (aMCI) and
nonamnestic MCI (naMCI), the neuropathological bases of these two subtypes remain …
nonamnestic MCI (naMCI), the neuropathological bases of these two subtypes remain …
Non-invasive brain stimulation in Alzheimer's disease and mild cognitive impairment—a state-of-the-art review on methodological characteristics and stimulation …
Background: Transcranial magnetic stimulation (TMS) and transcranial direct current
stimulation (tDCS) have been proposed as a new therapeutic way to enhance the cognition …
stimulation (tDCS) have been proposed as a new therapeutic way to enhance the cognition …
Focused ultrasound-induced blood-brain barrier opening enhances GSK-3 inhibitor delivery for amyloid-beta plaque reduction
Alzheimer's disease (AD) is a neurodegenerative disease that is the leading cause of age-
related dementia. Currently, therapeutic agent delivery to the CNS is a valued approach for …
related dementia. Currently, therapeutic agent delivery to the CNS is a valued approach for …